ExpreS2ion announces formation of Infectious Diseases Scientific Advisory Board
Hørsholm, Denmark, March 9, 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") today announces the establishment of an Infectious Diseases Scientific Advisory Board (ISAB). The four initial members of the ExpreS2ion ISAB bring a depth of knowledge in infectious diseases, clinical trials and preventive vaccines, and will contribute to the development of ExpreS2ion’s proprietary pipeline efforts in the infectious diseases field. The ISAB will serve as advisors and participants in key opinion leader events for the scientific community and investors.